GLAXOSMITHKLINE PHARMACEUTICALS LTD. Q1 FY26 Results
GLAXOQ1 FY26 ResultsAnnounced 1 Aug 2025, 12:37 pm| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 805.17 | 17.4% |
| Total Income | 848.89 | 16.4% |
| Expenditure | 569.91 | 13.2% |
| PBT | 278.98 | 22.2% |
| Net Profit | 205.01 | 22.0% |
| OPM | 31.20% | 3.00pp |
| NPM | 24.15% | 1.75pp |
| EPS | 12.10 | 22.0% |
Informational and educational content only. Not investment advice.